Kannalife, Inc. is a biopharmaceutical company focused on the development of proprietary and patented cannabidiol (CBD) and CBD-like molecules for patients suffering from unmet medical needs of neurodegenerative disorders - including chemotherapy-induced peripheral neuropathy (CIPN), a chronic neuropathy caused by toxic chemotherapeutic agents; hepatic encephalopathy (HE), a neurotoxic brain-liver disorder caused by excessive concentrations of ammonia and ethanol in the brain; mild traumatic brain injury (mTBI), a disorder associated with single and repetitive impact injuries; and chronic traumatic encephalopathy (CTE) a disease associated with highly repetitive impact injuries in professional and amateur sports. The Company's family of proprietary molecules focuses on treating oxidative stress-related diseases such as HE, chronic pain from neuropathies like CIPN, and neurodegenerative diseases like CTE. Kannalife conducts its research and development efforts at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.

IR Nav

Tear Sheet IR Contacts Subscribe to News Alerts RSS Feed

Company Profile

Pennsylvania Biotechnology Center
3805 Old Easton Road
Doylestown, PA 18902

(215) 695-6559

(516) 960-9212



Intraday stock chart for KLFE


Dean Petkanas

Chairman & CEO

William A. Kinney, PhD

Chief Scientific Officer

Thoma Kikis

Chief Communications Officer, Board Director

Mark Corrao

Chief Financial Officer

View Management Team

Past Six Months

6 month stock chart for KLFE

Recent News & Filings

10-K - Dec 31, 2019 10-Q - Mar 31, 2020

Investor Relations

Investor Relations Firm
377 Oak Street
Garden City, NY 11530
(516) 222-2285
Contact: John Marco

Transfer Agent

Securities Transfer Corp.
2901 Dallas Parkway, Suite 380, Plano, TX 75093
(469) 633-0101


DBB McKennon
12790 El Camino Real #130
San Diego, CA 92130
(858) 217-4035

Corporate Counsel

Procopio, Cory, Hargreaves & Savitch LLP.
525 B Street, Suite 2200
San Diego, CA 92101
(619) 238-1900

Subscribe to IR news and filing alerts

You can opt out at any time. We do not share or sell your info.